ASRM is dedicated to the advancement of the science and practice of reproductive medicine through advocacy, education, research, and ethical patient care.
Dear @SenTuberville: We can't speak to allegations of "furry culture" among pilots. But we do know this: Ill-informed politicians shouldn't threaten to send physicians to prison for providing necessary medical care. al.com/politics/2026/09/tube…
🔊anti-abortion extremists are pushing disinformation.
Mifepristone is safe. It's effective. And it's been used for decades.
The problem isn't science. It's a political campaign to restrict abortion access.
Know what's happening. Help us fight back by sharing the truth.
ALT The image features a bold message about Mifepristone. It states that the drug is safe, effective, and FDA-approved for decades. The message warns that anti-abortion extremists are attempting to restrict it. It concludes with "Know the facts. Fight the attacks." Pills frame the border. The phrase "Reproductive Freedom for All" appears at the bottom. The background is purple.
The incomparable Drs. Micah Hill and Ginny Ryan visited the Hill on Thursday to advocated for fertility treatment coverage for service members and veterans! ASRM thanks them for using their expertise to expand access to these essential services.
PRIMED Hill Day was a smashing success thanks to an incredible group of scholars, leadership from the CPL, and support from the CMC!
We thank the PRIMED cohort for sharing their expertise with policymakers in DC, deepening the conversation around reproductive medicine access.
We can’t wait to see the impact these scholars will have on the field for years to come.
Interested in making a difference you can see? Applications for the fourth PRIMED cohort open in October. Stay tuned. ⭐
New Special Statement published today in SMFM Pregnancy Journal:
SMFM highlights that #abortion care and counseling are central to maternal-fetal medicine practice and cannot be separated from high-risk pregnancy care, calling for institutional consensus-building to protect patient access in abortion-restrictive states.
Statement co-author Justin Lappen, MD, chair, SMFM Reproductive Health Committee, comments below.
Read a full breakdown of the new Special Statement: hubs.li/Q04xyw8M0
Menopause care is health care! ASRM thanks @SenGillibrand (D-NY) for leading the first-ever Congressional hearing on menopause, addressing research, coverage for treatments, and policy reform. usatoday.com/story/life/heal…
The PRIMED scholars are here! 📍 On the agenda for today: Prep for Wednesday's 's Hill day by reviewing issue briefs, meeting schedules, and general run-of-show.
¡Feliz Día Nacional del Registro de Votantes! Desde 2012, el NVRD ha ayudado a más de 6 millones de personas a registrarse para votar. Tómate 2 minutos para verificar tu estado de registro de votante: vote.health/social@NatlVoterRegDay#VoteReady#Democracy#VotER
🚨 The ASRM Office of Public Affairs and Center for Policy & Leadership are gearing up for the annual PRIMED trip to DC! Members of the third cohort will convene at ASRM HQ tomorrow and spend Wednesday advocating and taking meetings on the Hill. 🏛️
Stay tuned for updates!
Ahead of oral arguments in LA v. FDA, ASRM reasserts that using mifepristone for miscarriage care and medication abortion is safe, effective, & supported by decades of clinical evidence. Restricting access makes care more expensive & out of reach, harming patients and providers.
Let’s be clear:
Mifepristone is SAFE. FULL STOP.
✔️ 25+ years of efficacy evidence
✔️ Used by millions in the U.S.
✔️ Serious complications are exceedingly rare
So why is it under attack? Politics—not science.
Get the facts ⬇️
reproductiverights.org/resou…